In This Article:
Over the last 7 days, the Indian market has risen 1.1%, driven by gains in the Financials and Consumer Discretionary sectors of 0.9% and 1.6%, respectively, while climbing an impressive 41% over the past year. In this dynamic environment, identifying stocks with strong growth potential and solid fundamentals can be key to enhancing your portfolio's performance.
Top 10 Undiscovered Gems With Strong Fundamentals In India
| Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
|---|---|---|---|---|
| Bengal & Assam | 4.48% | 1.53% | 51.11% | ★★★★★★ |
| Wealth First Portfolio Managers | NA | -47.95% | 40.47% | ★★★★★★ |
| Goldiam International | 0.74% | 10.81% | 15.85% | ★★★★★★ |
| Vidhi Specialty Food Ingredients | 7.27% | 11.00% | 4.02% | ★★★★★★ |
| Bharat Rasayan | 8.15% | 0.10% | -7.93% | ★★★★★★ |
| Master Trust | 37.05% | 27.64% | 41.99% | ★★★★★☆ |
| Ingersoll-Rand (India) | 1.05% | 14.88% | 27.54% | ★★★★★☆ |
| Nibe | 39.26% | 80.75% | 84.69% | ★★★★★☆ |
| Insolation Energy | 88.64% | 163.87% | 419.31% | ★★★★★☆ |
| Monarch Networth Capital | 32.66% | 31.02% | 50.24% | ★★★★☆☆ |
Let's dive into some prime choices out of from the screener.
LT Foods
Simply Wall St Value Rating: ★★★★★★
Overview: LT Foods Limited engages in the milling, processing, and marketing of branded and non-branded basmati rice and rice food products in India with a market cap of ₹152.77 billion.
Operations: The primary revenue stream for LT Foods comes from the manufacture and storage of rice, generating ₹81.21 billion. The company's market cap stands at ₹152.77 billion.
Earnings for LT Foods have surged by 35.7% over the past year, significantly outpacing the Food industry's 16.7%. The company boasts a price-to-earnings ratio of 25x, which is attractive compared to the Indian market's 34.6x. Its net debt to equity ratio has impressively dropped from 116.4% to 26.8% over five years, signaling strong financial health. Additionally, earnings are forecasted to grow by another 10.53% annually, and interest payments on its debt are well covered with EBIT at a robust 10.8x coverage level.
-
Get an in-depth perspective on LT Foods' performance by reading our health report here.
-
Understand LT Foods' track record by examining our Past report.
Marksans Pharma
Simply Wall St Value Rating: ★★★★★★
Overview: Marksans Pharma Limited, along with its subsidiaries, focuses on the research, manufacturing, marketing, and sale of pharmaceutical formulations across various international markets including the United States, North America, Europe, the United Kingdom, Australia, and New Zealand with a market cap of ₹134.31 billion.
Operations: Marksans Pharma Limited generates revenue primarily from the sale of pharmaceutical formulations, amounting to ₹22.68 billion. The company's market cap stands at ₹134.31 billion.